B1 bradykinin receptor antagonists

Details B1 bradykinin receptor antagonists B1 bradykinin receptor antagonists

2005-10-11

2008-08-19

McKane, Joseph (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S247000, C548S255000, C548S256000

Reexamination Certificate

active

07414134

ABSTRACT:
The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.

REFERENCES:
patent: 6667331 (2003-12-01), Duplantier et al.
patent: 2003/0073641 (2003-04-01), None
patent: 2004/0116353 (2004-06-01), None
patent: WO95/14683 (1995-06-01), None
patent: WO 97/26315 (1997-07-01), None
patent: WO 02/076964 (2002-10-01), None
patent: WO2004/083173 (2004-09-01), None
patent: WO2004/092116 (2004-10-01), None
patent: WO2004092164 (2004-10-01), None
Viral Infections [online], [retrieved on Sep. 8, 2006]. Retrieved from the Internet, URL;http://en.wikipedia.org/wiki/Viral—infections>.
Shih et al., Selective Human Enterovirus and Rhinovirus Inhibitors: An Overview of Capsid-Binding and Protease-Inhibiting Molecules. Medicinal Research Reviews, 2004, vol. 24, No. 4, pp. 449-474.
Clerq, Antiviral drugs in current clinical use. Journal of Clinical Virology, 2004, vol. 30, pp. 115-133.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 2050-2057.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 1992-1996.
FDA mulls drug to slow late-stage Alzheimer's [online], [retrieved on Sep. 23, 2003]. Retrieved from the Internet, URL; http://www.cnn.com/2003/HEALTH/condtions/09/24/alzheimers.drug.ap/indexhtml>.
Su, Dai-Shi, et al., “Discovery of a Potent, Non-peptide Bradykinin B1Receptor Antagonist,”J. Am. Chem. Soc., vol. 125, pp. 7516-7517, 2003.

Affiliated with

Also associated with

Rating

B1 bradykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with B1 bradykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and B1 bradykinin receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4001262